05/24/03



Franklin Charles Lowe, MD MPH

171 West 71 Street, Apt 4E

New York, NY 10023

Contact Information: FCLOWEMD@

(c) 917-865-6035

(o) 718-920-4531

Academic Training: Princeton University, B.A. 1975

Columbia University, M.D. 1979

Columbia University, M.P.H. 1979

Licenses: National Boards #211443 1980

Maryland #D26397 1981

Pennsylvania #MD032818-E 1984

New York #161-819 1985

Massachusetts #150229 1996-2112

Traineeship: Internship in Surgery Johns Hopkins 1979-1980

Residency in Surgery, Johns Hopkins 1980-1981

Residency in Urology, Johns Hopkins 1981-1982

Research Fellow in Urology, John Hopkins 1982-1983

Residency in Urology, Johns Hopkins 1983-1984

Board Qualifications: American Board of Urology #9115 1987

American Board of Urology Recertification 1995,2006,2015

Professional American Public Health Association 1976-1982

Organizations: American Medical Association 1978-2000

NY Section, American Urological Association 1986-present

1992-2001 Bylaws Committee

1993-2001 Chairman

1992-1994 Rep. AUA Audiovisual Com.

1993-2001 Rep. AUA Bylaws Committee

1998, 2003 Scientific Program Co-Chairman

2006-2009 Executive Board

American Urological Association 1987 – present

1993-2001 Bylaws Committee

1996-2003 BPH Guidelines Panel

1998-2009 Alternative Medicine Committee

2001-2009 Chairman

2001-present Annual Meeting Program Committee

2001-present Communications Comm., Expert Panel

St. Luke’s/Roosevelt Hospital

Physicians’ Organization 1986-1993

1987. Vice President

1987-1990 President

1990-1993 Secretary`

American Cancer Society 1986-1998

1993. Lecturer

1995. Professional Education

Grants Committee

American College of Surgeons 1988-2005

American Geriatrics Society 1988-1991

New York Academy of Medicine 1990-present

2001. Executive Board:

Section Urology

2000. Secretary

2001. President

New York State Urological Association 1993-present

American Association of Clinical Urologists 1993-present

Societe International D-Urologie 1994-present

AUA Foundation 2010-present

2010-2012 Education Council

Academic

Appointments: Instructor in Urology, John Hopkins 1985

Assistant Prof. of Clinic Urology, Columbia 1985-1994

Adjunct Asst. Prof. of Urology, Cornell 1987-2007

Associate Clinical Prof. of Urology, Columbia 1994-1997

Associate Prof. of Clinical Urology, Columbia 1997-2003

Professor of Clinical Urology, Columbia 2003-2014

Professor of Urology, Mount Sinai 2014-2015

Hospital

Appointments: Assistant Chief of Service Urology, John Hopkins 1985

Jr. Assistant Attending, St. Luke’s-Roosevelt 1985-1987

Associate Attending, St. Luke’s-Roosevelt 1987-1994

Senior Attending, St. Luke’s-Roosevelt 1995-2015

Assistant Attending, New York Hospital

Cornell Medical Center 1987-2013

Associate Attending, Columbia Presbyterian 1998-2013

Attending, Montefiore Medical Center 2015-present

Honors: Second Prize – Laboratory Research

Mid-Atlantic American Urological Association 1983

First Prize – Clinical Research

Mid-Atlantic, American Urological Association 1984

Best paper on Prostatic Disease, NY AUA 1992

Prostate Health Council-American Foundation

For Urologic Disease.

Castle and Connolly

Best Doctors in NY Metro Area 1997-present

Best Doctors in America 1998-present

America’s Top Doctors for Cancer 2000-present

New York Magazine 1998-2014

Best Doctors in New York

Pfizer Scholars in Urology 1998

Camp Winadu Humanitarian Award 1998

Teacher of the Year 2001

Columbia P & S, Urology

Marquis’ Who’s Who in America 2005

New York Times—Super Doctors 2008-present

SLD’s Guide to America’s Top Urologists 2009-present

America’s Choice - Most Compassionate Doctor 2008- present

Newsweek Magazine- Best Doctors for Cancer 2015

Grants: Abbott Laboratories 1989 -1990

Principal Clinical Investigator $66,000

Terazosin for BPH

Abbott Laboratories 1990 -1994

Principal Clinical Investigator $120,000

Long-term Therapy with Terazosin

Abbott Laboratories 199 2-1994

Principal Clinical Investigator $ 50,000

Terazosin vs. Placebo

Miles Pharmaceutical 1993 -1994

Principal Clinical Investigator $ 30,000

Low Dose Cipro for UTI

Abbott Laboratories 1994 -1998

Principal Clinical Investigator $ 30,000

Long-term Therapy with Terazosin

Merck 1988 -1992

Co-Investigator

Finasteride for BPH

Abbott Laboratories 1992 -1994

Co-Investigator

Terazosin vs. Placebo

Matrix Pharmaceutical 1993 -1994

Co-Investigator

5-FU Implant for Prostate Cancer

lCl-Zeneca 1992 -present

Co-Investigator

Combined Androgen Deprivation for Prostate Cancer

Vivus 1994 -1996

Co-Investigator

Intra-urethral Aprostadil for Impotence

ICl-Zeneca 1996-present

Co-Investigator

Adjunct Casodex Following Radical Prostatectomy

Gallaxo-Wellcome $20,000 1997-1998

Investigator

5 alpha reductase inhibitor for BPH

Merck $25,000 1999-2001

Investigator

Proscar for Hematuria

Novogen $20,000 1999-2000

Investigator

Trinovan (lsoflavone) or BPH

NIH-NIDDK 2002-2005

Co-Investigator

Phytotherapy for BPH

Departmental: Chief of Urology Clinics, St. Luke’s/Roosevelt 1985-2015

Director of Resident Education, SL/R 1986-2015

Associate Director, St. Luke’s 1989-2015

Hospital

Committees: Transfusion 1986-1999

Medical Options Planning 1986-1988

Future of St. Luke’s 1989-1994

St. Luke’s-Roosevelt PPO Planning 1990-1991

Medicaid Managed Care Planning 1992-1993

Managed Care 1993-1994

Physician/Hospital Task Force 1993-1994

Associate Director 1995-1997

Clinical Practice 2003-2007

Professional

Activities: Editorial

Journal of Urology, Reviewer 1988-present

Archives of Dermatology, Reviewer 1990

Urology, Reviewer 1993-present

Editorial Board 1998-2008

Associate Editor, Infections 1999-2008

Medical Letter, Editorial Consultant 1994

Pharmaco Economics, Reviewer 1996

AIDS, Reviewer 1996

AMA Drug Evaluations, Editorial Consultant 1994, 1997

Prostate Health. Com. Editorial Board 1997-2001

Pharmacopeia, Reviewer 1997-1998

Gender and Health, Editorial Board 1998-1999

Consumer Reports on Health, Reviewer 1998-present

Urology Research and Treatment, Editorial Board 1999-present

The 5 Minute Urology Consult, Section Editor 2000, 2010, 2014

Prostate Cancer and Prostatic Diseases

Consulting Editor 2000-2015

Office of Dietary Supplements, NIH

Botanical Fact Sheet 2002

Brazilian Journal of Urology

Consulting Editor, BPH 2005-present

Clinical Therapeutics

Editorial Consultant 2004-present

Consultant

Kellogg Grant to Johns Hopkins,

Advisory Board 1982-1985

PruCare of New York

Credentials Committee 1987 - 1992

Schering-Plough Pharmaceuticals,

Consultant, Sales Training 1990 – 1995 Chubb Health,

Physician Advisory Panel 1994 – 1998

4th International Consultation on BPH

Committee on Other Medical Therapies 1997

5th International Consultation on BPH

Co-Chairman, Committee on Other

Medical Therapies 2000

NIH Saw Palmetto Study

Data & Safety Monitoring Board 2000 – 2005

Columbia University Halth Service, Ask Alice

Health Information Service 1996 – 2002

Empire BC, Provider Appeals 2001 – 2002

3rd International Consultation on PCa

Committee on Supplemental Hormonal Treatment 2002

FDA – Special Drug Consultant 2002 – 2010

National Kidney Foundation –NY Section 2005 --2010

Medical Advisory Board

NIDDK Prostate Basic and Clinical Science Strategic Planning 2007

Committee

NY State-DOH Office Professional Medical Conduct 2008 - present

Medical Expert

Other Activities:

Princeton University

Schools Committee 1975 – 2006

Interviewer 1975 – 2005

Co-Chairman, Bronx 2003 – 2006

Annual Giving, Solicitor 1995 , 1998

P & S Alumni Association 1997 – 2002

Executive Council

Manhattan Soccer

Head Coach 1985-86 Travel Team 1995 – 2003

Head Coach 1988-89 Travel Team 1997 – 2001

Board of Directors 2000 – 2003

Second Vice President 2001 – 2002

Horace Mann School

Development Office 1989 – present

Class Agent 1995 – present

Annual Fund ’99, Chairman 1998 – 1999

Annual Fund 2000, Co-Chairman 1999 – 2000

Annual Fund 2001, Co-Chairman 2000 – 2001

Annual Fund 2002, Co-Chairman 2001 – 2002

Annual Fund 2003, Co-Chairman 2002 – 2003

Annual Fund 2004, Co-Chairman 2003 -- 2004

Capital Campaign, Alumni Chair 2002 – 2005

Annual Fund 2005, Co-Chairman 2004 –2005

Annual Fund 2006, Alumni Chair 2005-2006

The Dorilton Co-op Board of Directors 1998 – present

Congregation Rodeph Sholom 2002 – 2006

Board of Trustees

United States Soccer Federation 2003-2011

Certified Referee

Publications:

Peer Reviewed

1. Lowe,F.C. and Jeffs, R.D.: Wound Dehiscence in Bladder Exstrophy:

An Examination of the Etiologies and Factors for initial Failure and Subsequent Success.

J. Urol. 130:312-318, 1983.

2. Lowe,F.C: Squamous Cell Carcinoma of the Scrotum: A Review. J. Urol. 130:423-

427, 1983.

3. Lowe,F.C. and Jeffs, R.D.: lleal Trigonal Conduits: 10 Year Follow-up.

Urol. 130:874-877, 1983.

4. Lowe,F.C and Isaacs, J.T.: Biochemical Methods for Predicting Metastatic Ability

Of Prostatic Cancer Utilizing the Dunning R-3327 Rat Prostatic Adenocarcinoma System

as a Model. Cancer Research 44:744-752, 1984.

5. Lowe,F.C and Marshall, F.F.: Ureteropelvic Junction Obstruction in Adults.

Urology 23:331-336, 1984.

6. Brendler, C.B., Albertson, P.C. Goldman, S.M., Hill, G.S., Lowe, F.C. and Millan, J.D.:

Acquired Renal Cystic Disease in the End-Stage Kidney. J. Urol. 132:548-552, 1984.

7. Lowe,F.C and Brendler, C.B.: Penile Gangrene: A Complication of Secondary

Hyperparathyroidism from Chronic Renal Failure. J. Urol. 132:189-191, 1984.

8. Lowe,F.C.: Squamous Cell Carcinoma of the Scrotum. Urology 25:63-65, 1985.

9. Lowe,F.C and Mc Cullough, A.R.: Cutaneous Horns of the Penis: An approach

To Management. J. Amer. Acad. Dermatol. 12:369-373, 1985.

10. Lowe,F.C., Hill G., Jeffs, R.D. and Brendler, C.B.: Urethral Prolapse in Children:

Insights into Etiology and Management. J. Urol, 135:100-103, 1986.

11. Lowe,F.C., Auster, M., Geck, T. Chang, R. and Marshall,

F.F.: Monitoring Radiation Exposure to Medical Personnel During Percutaneous

Nephrolithotomy. Urology 28:221-226, 1986.

12. Gearhart, J.P. and Lowe, F.C.: Genitalia Injuries from Breakdancing in Children and

Adolescents. Pediatrics 77:92-924, 1986.

13. Somers, W.J. and Lowe,F.C.: Localized Gangrene of the Scrotum and Penis: A

Complication of Heroin Injection into the Femoral Vessels. J. Urol. 136:111-113,

1986.

14. Lowe,F.C. and Walther, J.M.: Case Profile: Emphysematous Pyelonephritis.

Urology 28:532-533, 1986.

15. Walther, J.M., Romas, N.A. and Lowe, F.C.: Barium Granuloma: An Unusual Cause

of Unilateral Ureteral Obstruction. J. Urol. 138:614-616, 1987.

16. Lowe,F.C. and Somers, W.J.: The Use of Ketoconazole in the Emergency

Management of Disseminated Intravascular Coagulation Due to Metastatic Prostate

Cancer. J. Urol. 137:1000-1003, 1987.

17. Walsh, P.C., Epstein, J.l. and Lowe, F.C.: Potency Following Radical Retropubic

Prostatectomy with Wide Unilateral Excision of the Neurovascular Bundle. J. Urol.

138: 823-827, 1987.

18. Oesterling, J.E., Goldman, S.M. and Lowe, F.C.: Intravesical Herniation of Small

Bowel Following Bladder Perforation. J. Urol. 138: 1236-1238, 1987.

19. Somers, W.J., TerPenning, BG., Lowe, F.C. and Romas, N.A.: Renal Parenchymal

Neurilemmoma: A Rare and Unusual Kidney Tumor. J. Urol. 139: 109-110, 1998.

20. Bamberger, M.H., and Lowe, F.C.: Ketoconazole in Initial Management and

Treatment of Metastatic Prostate Cancer to the Spine. Urology 32:301-303, 1988.

21. Lowe, F.C. , Fishman, E.K. and Oesterling, J.E.: Use of Computerized Tomography in

Diagnosis of Bladder Rupture. Urology 33:341-343, 1989.

22. Lowe, F.C., Lattimer, D.G. and Metroka, C.E.: Kaposi’s Sarcoma of the Penis in

Patients with Acquired Immune Deficiency Syndrome. J. Urol. 142:1475-1477, 1989.

23. Lowe, F.C., Goldman, S.M. and Oesterling, J.E.: Computerized Tomography in the

Evaluation of Transitional Cell Carcinoma in Bladder Diverticula.

Urology 33:390-395, 1989.

24. Lowe, F.C., and Bamberger, M.H.: The Indications for the Use of Ketoconazole in

the Management of Metastatic Prostate Cancer. Urology 36:541-545, 1990

25. Coleburn, N., Scholes, J. and Lowe, F.C.: Renal Failure in Patients with AIDS Related

Complex. Urology 37:523-527, 1991.

26. Sigalow, D.A., Waldbaum, R.S. and Lowe, F.C.: The Influence of Modern Radiographic

Imaging Techniques in Identifying Asymptomatic Renal Cell Carcinomas. New York

State Journal of Medicine 91:200-202, 1991.

27. Lepor, H., Auerback, S., Puras-Baez A., Narayan, P., Soloway, M. .Lowe, F.C., Moon, T.,

Leifer, G. and Madsen, P.: A Randomized, Placebo-Controlled Multicenter Study of

the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

J. Urol. 148:1467-1474, 1992.

28. Kwan, D. and.Lowe, F.C.: Congenital Bladder Diverticulum: An Unusual Presentation

With Abdominal Mass, Urinary Retention and Renal Failure in a Young Adult.

Urologic Radiology 14:194-196, 1992.

29. Oesterling, J.E., Martin, S.M., Bergstralh, E.J. and .Lowe, F.C.: The Use of Prostate-

Specific Antigen in Staging Patients with Newly Diagnosed Prostate Cancer. J.A.M.A.

269:57-60, 1993.

30. .Lowe, F.C.: and Stark, E.: The Use of Alpha Blockers in the Management of Benign

Prostatic Hyperplasia. New York State Journal of Medicine 93:169-173, 1993.

31. Lowe, F.C. and Jarow, J.P.: Placebo Controlled Study of Oral Terbutaline and

Pseudoephedrine in the Management of Prostaglandin El induced Prolonged Erection.

Urology 42:51-54, 1993.

32. Trauzzi, S.J., Kay, C.J. Kaufman, D.G. and Lowe, F.C.: The Management

of Prostatic Abscess in Patients with Acquired Immunodeficiency Syndrome.

Urology 43:629-633, 1994.

33. Lowe, F.C.: Safety Assessment of Terazosin in the Treatment of Patients with

Symptomatic Benign Prostatic Hyperplasia: A Combined Analysis. Urology 44:46-

51 1994.

34. Kwan, D. and Lowe, F.C.: Genitourinary Manifestations of AIDS.

Urology 45:13-27, 1995.

35. Klein, L.T. and Lowe, F.C.: Penile Gangrene: Associated with Extensive

Kaposi’s Sarcoma in AIDS Patients. Urology 46:425-428, 1995.

36. Lowe, F.C.: McDaniel, R.L., Chmiel, J.J. and Hillman A.L.: Economic

Modeling to Assess the Costs of Treatment with Finasteride, Terazosin and

TURP for Men with Moderate to Severe Symptoms of BPH.

Urology 46:477-483, 1995.

37. Weiner, D.M. and Lowe, F.C.: Surgical Management of Penile Gangrene

in Diabetics with End-Stage Atherosclerosis. J. Urology 155:926-929, 1996.

38. Weiner, D.M. and Lowe, F.C.: Epididymo-Cutaneous Fistula in an AIDS

Patient with Marfan’s Syndrome. Urology 47:766-768, 1996.

39. Lowe, F.C.. and Ku, J.C.: Phytotherapy in the Treatment of BPH: A Critical

Reappraisal. Urology, 48:12-20, 1996.

40. Staiman, V.R., O’toole, K.C., Rubin, M.A. and Lowe, F.C.:. Giant Malignant Fibrous

Histiocytoma of the Testis/Spermatic Cord: Psychological and Possible Etiologic

Complication of Unethical Nazi Medical Experimentation. Urology 48:939-943, 1996.

41. McKierman, J. and Lowe, F.C.:. Update on Safety Terazosin in the Treatment of BPH.

Southern Medical Journal 90:509-513, 1997.

42. Weiner, D.M. McDaniel, R.L. and Lowe, F.C.:. Urological Manpower Issues for the

Twenty First Century: Assessing the Impact of Changing Population Demographics.

Urology 49:335-342, 1997.

43. Jarow, J.P. and Lowe, F.C.:. Penile Trauma: An Etiologic Factor in Peyronie’s Disease

and Erectile Dysfunction, J. Urol. 58” 1388-1390, 1997.

44. Lowe, F.C.:. The Concomitant Usage of Tamsulosin with Other Antihypertensives:

The Lack of Clinically Significant Interactions, Clinical Ther. 19: 30-42, 1997.

45. Staiman, V.R. and Lowe, F.C.:. Tamoxifen for Flutamide – Induced Gynecomastia.

Urology 50: 929-933, 1997.

46. Lowe, F.C.and Fagelman, E.: Phytotherapy in the Treatment of Benign Prostatic.

Hyperplasia. Current Opinion in Urology 8:27-29, 1998.

47. Weiner, D.M. and Lowe, F.C.: Psychotropic Drug Induced Priapism: Etiology and

Management. CNS Drugs 9: 371-379, 1998.

48. Klein, L.T. Frager, D. Subramanian, A. and Lowe, F.C.: Indications for the Use of

Magnetic Resonance Urography. Urology 92: 602-608, 1998.

49. Lowe, F.C.: Dreikorn, K., Borkowski, A., Braeckman, J. Denis, L., Ferrari, P., Gerber, G.,

Levin, R., Perrin, P., and Senge, T.: A Review of the Recent Placebo-Controlled

Trials Utilizing Phytotherapeutic Agents For The Treatment of BPH. Prostate 37:

187-193, 1998.

50. Lowe, F.C. and Fagelman E.: Phytotherapy in the Treatment of BPH: An Update.

Urology 53: 671-678, 1999.

51. Lowe, F.C., Olson P.J., Padley R.J.: The Effects of Terazosin Therapy on Blood

Pressure in Men with Benign Prostatic Hyperplasia Concurrently Treated With Other.

Antihypertensive Medications. Urology 54:81-85, 1999.

52. Albertsen P.C., Pellissier J.M., Lowe, F.C., Girman, C.J. and Roehrborn, C.G.:

Economic Analysis of Finasteride: A Model-Based Approach Utilizing PLESS Data..

Clinical Ther 21:1006-1024, 1999.

53. Lowe, F.C., and Fagelman, E.: Phytotherapy and Complementary Medications in

The Treatment of BPH and LUTS. Contemp. Urol. 14: 72-77, 1999.

54. Lowe, F.C.: The Role of Alpha-Adrenergic Anatagonists in The Treatment of BPH.

Prostate Cancer and Prostate Disease 2: 110-119, 1999.

55. Boyle, P., Robertson, C., Lowe, F.C.: and Roehrborn, C.: Meta-Analysis of Clinical Trials

Of Permixon in The Treatment of Symptomatic Benign Prostate Hyperplasia. Urology 55:

533-539, 2000.

56. Lowe, F.C.: and Fagelman, E.: Phytotherapy for Chronic Prostatitis. Current Urology-

Reports 1: 164-166, 2000.

57. Narayan, P. and Lowe, F.C.: The Effects of Tamsulosin on Vital Signs in Two Multicenter,

Placebo-Controlled Studies. Cardiovascular Reviews and Reports 21: 494-499, 2000.

58. Lowe, F.C. and Fagelman, E.: Cranberry Juice and Urinary Tract Infections: What is the

Evidence? Urology, 57: 407-413, 2001..

59. Lowe, F.C.: Phythotherapy in the Management of Benign Prostatic Hyperplasia

Urology 58 (6A): 71-77, 2001.

60. Fagelman, E. and Lowe, F.C.: Phythotherapy in the Treatment of Benign Prostatic Hyperplasia

Current Opinion in Urology, 12: 15-18, 2002.

61. Lowe, F.C.: Goals for Benign Prostatic Hyperplasia Therapy.

Urology 59 (2A): 1-2, 2002.

62. Marks, L., DiPaola, R.S., Nelson, P., Chen S., Heber, D., Belledegrun, A.S., Lowe, F.C., Fan, J., Leaders, F.E., Pantuck, A.J., and Tyler, V.E.: PC SPES: Herbal Formulation for Prostate Cancer. Urology 60: 369-377, 2002.

63. Lam, J., Romas, N.A. and Lowe, F.C.: Long-term Treatment with Finasteride in Men

With Symptomatic Benign Prostatic Hyperplasia: 10 Year Follow-up. Urology 61: 354-

358, 2003.

64. Lowe, F.C., et al: Long-term 6 Year Experience with Finasteride in Patients with

Benign Prostatic Hyperplasia: Urology 61: 791-796, 2003.

65. Lowe,F.C., Gilbert, S.M. and Kahane, H.: Evidence of Increased Prostate Cancer Detection in Men

Aged 50 to 59: A Review of 324,684 Biopsies Performed Between 1995 and 2002. Urology 62: 1045-49, 2003.

66. Weiner, D.M. and Lowe,F.C.: Alfuzosin for the Management of Benign Prostatic Hyperplasia.

Expert Opinion in Pharmacotherapy 4: 2057-2063, 2003.

67. AUA Practice Guidelines Committee: AUA Guideline on Management of Benign Prostatic Hyperplasia(2003)

Chapter 1: Diagnosis and Treatment Recommendations. J. Urol: 170:530-547, 2003.

68. Lowe,FC: Patient Risk Profiles for Progression of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH). European Urology: Supplement 3: 7-11, 2004.

69. Fagelman, E. and Lowe,F.C.: Permixon: An Update. Current Prostate Reports 2:133-136, 2004.

70. Boyle,P., Robertson, C., Lowe, F.C., Roehrborn, C.: Updated Meta-analysis of Clinical Trials of Serenoa Repens Extract in the Treatment of Symptomatic Benign Prostatic Hyperplasia. BJU Int 93:751-757, 2004.

71. Lowe, F.C.: Role of the Newer Alpha-Adrenergic-Receptor Antagonists in the Treatment of Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms. Clinical Therapeutics: 26:1701-1713, 2004.

72. Levinson, A., Nagler, E.A., Lowe, F.C.: Approach to Management of Clinically Localized Prostate Cancer in HIV Positive Patients. Urology: 65: 91-94, 2005.

73. Lowe, F.C., Batista J., Berges, R., Chartier-Kastler, E., Conti, G., Desgrandchamps, F., Dreikorn, K., O’Leary, M., Perez, M.,Speakman, M., Trachtenberg, J., Tubaro, A., Meesen, B., Smets, L., Stovelaar, H.: Risk Factors for Disease Progression in Patients with Lower Urinary Tract Symptoms/Begnin Prostatic Hyperplasia (LUTS/BPH): A Systematic Analysis of Expert Opinion. Prostate Cancer & Prostate Diseases 8: 206-209, 2005.

74. Gilbert, S.M., Cavallo, C.B., Kahane, H., Lowe, F.C.: Evidence Suggesting a PSA Cut-Point of 2.5 nanograms

per milliliter for Prompting a Prostate Biopsy: A Review of 36,316 Patients. Urology 65: 549-553, 2005.

75. Santillo, V.M. and Lowe, F.C.: Prostate Cancer and the Gay Male. J. Gay & Lesbian Psychotherapy

9: 9-27, 2005.

76. Lowe, F.C.: Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Sexual Function. BJU Int.

95: (s4) 12-18, 2005.

77. Speakman, M., Batista, J., Berges, J., Chartier-Kastler, E., Conti, G., Desgrandchamps, F., Dreikorn, K.,

Lowe,F.C., O’Leary, M., Perez, M., Trachtenberg, J., Tubaro, A., Meesen, B., Smets, L., Stovelaar, H.:

Integrating Risk Profiles for Disease Progression in the Treatment Choice for Patients with Lower UrinaryTract

Symptoms/Benign Prostatic Hyperplasia: A Combined Analysis of External Evidence and Clinical Expertise.

Prostate Cancer & Prostate Diseases 8: 369-374, 2005.

78. Santillo, V.M. and Lowe,F.C.: Role of Vitamins, Minerals and Supplements in the Prevention and Management

of Prostate Cancer. Brazilian International J. Urol 32:3-14, 2006.

79. Santillo, V.M. and Lowe,F.C. : Treatment of Prostatitis in HIV Positive Patients. Current Urol Reports. 7:313-319, 2006.

80. Santillo, V.M. and Lowe, F.C.: The Management of Chronic Prostatitis in Men with HIV. Current Prostate Reports 4:93-99, 2006.

81. Santillo, V.M. and Lowe, F.C.: Cranberry Juice for the Prevention and Treatment of Urinary Tract Infections.

Drugs of Today 43: 47-54, 2007.

82. Sprenkle, P.C. and Lowe, F.C.: Benign Prostate Hyperplasia in the Older Male. Aging Health 3:177-189, 2007.

83. Lowe, F.C. and Patel, T.: Complementary and Alternative Medicine in Urology: What We Need to Know in 2008. BJU Int 97: 422-424, 2008.

84. Moyad, M.A. and Lowe,F.C.: Educating Patients About Lifestyle Medications for Prostate Health. Am. J. Med.

121: S34-S42, 2008.

85. Lowe, F.C.: The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. European Urology Sup 8: 894-897, 2009.

86. Wosnitzer, M.S. and Lowe, F.C.: Management of Prostate Cancer in HIV-positive Patients. Nat. Rev. Urol.

7:348-357, 2010.

87. Weiss, J.P., Blavais, J.G., Bliwise, D.L., Dmochowski, R.R., DuBeau,C.E., Lowe, F.C., Petrou, S.P., and van Kerrebroeck, P.E.V., Rosen, R.C., and Wein, A.J.: The Evaluation and Treatment of Nocturia: A Consensus Statement. BJU Int 108:6-21, 2011.

88. Suh, L.K. and Lowe,F.C.: Alternative Therapies for the Treatment of Chronic Prostatitis.

Current Prostate Reports 12:284-287, 2011.

89. Cubillos, J., Palmer, J.S., Freedman, S.C., Fregel, J., Lowe, F.C., and Palmer, L.: Familial Testicular Torsion.

J. Urol 185: (6 suppl) 2469-72, 2011.

90. Rhoerborn, C., Lowe,F.C., Gittelman, M., Verbeek, A.E, Wruck, J.: Feasibility of An Alternative Option For Management of Male Lower Urinary Tract Symptoms. J Urol 195: in press, 2016.

Invited Articles:

1. Oesterling, J.E. and Lowe,F.C.: Squamous Cell Carcinoma of the Scrotum.

AUA Update Series: 1X, 178-184, 1990.

2. Lowe,F.C. and Barnswell C.: Urinary Tract Infestions in Women.

The Female Patient 19: 19-26, 1994.

3. Ku, J.C. and Lowe,F.C..: Current Approach to Interstitial Cystitis.

The Female Patient 20: 27-34, 1995.

4. Kay, C.J., Trauzzi, S.J. and Lowe,F.C..: Prostatic Abscess in Patients.

with Acquired Immunodeficiency Syndrome: Imaging and Management.

Infections in Urology 8:86-90, 1995.

5. Staiman, V.R. and Lowe,F.C..: The Spectrum of Prostatic Diseases in

HIV Patients: Prostatic Abscess – An Emerging Problem. The AIDS Reader

5: 165-171, 1995.

6. Kwan, D. and Lowe,F.C..: Acquired Immunodeficiency Syndrome in Urology:

Part 1: AIDS and the Urologist. AUA Update Series XIV:297-304, 1995.

7. Kwan, D. and Lowe,F.C..: Acquired Immunodeficiency Syndrome in Urology:

Part 1l: Genitourinary Manifestations of AIDS. . AUA Update Series XIV:-305-312, 1995.

8. Kay, C.J., Trauzzi, S.J. and Lowe,F.C..: Imaging and Management of Prostatic Abscess

Associated With the HIV syndrome. Infections in Medicine 12:535-539, 1995.

9. Staiman, V.R. and Lowe,F.C..: Prostatic Disease in HIV-Infected Patients.

Infections in Urology 9:42-47, 1996.

10. Staiman, V.R. Kwan D..and Lowe,F.C..: Genitourinary Manifestations of AIDS.

Infections in Urology 9:73-77,92, 1996.

11. Klein, L.T. Lowe,F.C..: HIV in Women. Update on Transmission.

The Female Patient 21:13-21, 1996.

12. Staiman, V.R., Kwan, D.J. and Lowe,F.C.: HIVand the Genitourinary Tract.

Infections in Medicine 13:598-608, 1996.

13. Lowe,F.C..: Saw Palmetto Berry in the Treatment of BPH, Clin. Res. Reg. Affairs.

14:53-66, 1997.

14. Staiman, V.R. and Lowe,F.C..: Prostatic Disease in HIV-Infected patients. Primary

Care Review: Update on Urology, 3: (1) 19-24, 1997.

15. Staiman, V.R. Kwan, D.J. and Lowe,F.C..: Genitourinary Manifestations of AIDS.

Care Review: Update on Urology, 3: (1) 9-15, 1997.

16. Weiner, D.M. and Lowe,F.C..: Gangrene of Penis. AUA Update Series: XVII, 42-49,

1998.

17. Lowe,F.C. and Fagelman E.: Using Complementary Medications to Treat BPH.

Patient Care :191-203,2000.

18. Fagelman, E., and Lowe, F.C.: Using Complementary Medications for BPH. Reviews

in Urology, 3:134-138, 2001.

19. Hyun, G., Staiman V.R. and Lowe, F.C: Urological Problems in Patients with Acquired

Immunodeficiency Syndrome. AUA Update Series: XXI, 313-320, 2002.

20. Johnson, C., Lowe, F.C., and Johnson, W.D.: Tuberculosis of the Genito-urinary System.

AUA Update Series: XXII: 301-308, 2003.

21. Staiman V.R. and Lowe, F.C.: Urologic Problems in Patients with Acquired Immunodeficiency Syndrome.

Scientific World J 4: (S1) 427-437, 2004.

22. Lowe,F.C.: Summary of Clinical Experiences With Tamsulosin for the Treatment of Benign

Prostatic Hyperplasia. Reviews in Urology 7: (S4), S13-S21, 2005.

23. Lowe,F.C. and Nagler, E.: Prostate Biopsy in the Diagnosis of Prostate Cancer: Current Trends and

Techniques. Drugs Today 41:179-191, 2005.

24. Santillo, V.M. and Lowe, F.C.,: Phytotherapy for BPH. AUA Update Series: XXV: in press, 2006.

25. Santillo, V.M. and Lowe, F.C. : Treatment of BPH in Men with Cardiovascular Disease.

Drugs and Aging 23:795-805, 2006.

26. Lowe, F.C.: Vitamins and Supplements: Concerns About Safety. AUA News 12:21, May, 2007.

27. Hansen, A.M., Santillo, V.M. and Lowe, F.C.: Phytotherapy for Benign Prostatic Hyperplasia.

Timely Top Med Urology. 8: E23, Oct, 2007.

28. Chughtai, B., Kavaler, E., Te, A., Kaplan, S.A. and Lowe, F.C. : Use of Herbal Supplements for Over Active

Bladder. Reviews in Urology 15:93-96, 2013.

29. Lowe,F.C. and Sunyaro,P.: Relationship Between the Metabolic Syndrome and Prostate Cancer.

AUA News 20(1)14, 2015.

Invited Chapters:

1. Lowe, F.C.: Surgery for Gangrene of the Male Genitalia. In Operative

Urology, Edited by F.F. Marshall, W.B. Saunders & Co.: Chapter 50 p 377-385, 1991.

2. Lowe, F.C. and Brendler, C.B.: Initial Evaluation of the Urological Patient. In

Campbell’s Urology, Sixth Edition, Edited by P.C. Walsh, W.B. Saunders & Co.:

1992.

3. Kwan, D. and Lowe, F.C.: Acquired Immunodeficiency Syndrome: A Venereal

Disease. Urol. Clinics N. Amer. 19:13-24, 1992.

4. Lowe, F.C.: Squamous Cell Carcinoma of the Scrotum. Urol. Clinics N. Amer.

1992.

5. Lowe, F.C.: and Lepor, H.: Alpha Blockers in the treatment of Benign Prostatic

Hypertrophy. In Management of Benign Prostate Hyperplasia. Edited by N.A. Romas

and E.D. Vaughan, Springer-Verlag: 173-183, 1993.

6. Lowe, F.C. and Trauzzi, S.J.: Prostatic Acid Phosphatase in 1993: It’s Limited

Clinical Utility. Urol. Clinics N. Amer. 10: 589-596, 1993.

7. Lowe, F.C.: Surgery for Gangrene of the Male Genitalia. In Operative Urology,

Second Edition, Edited by F.F. Marshall, W.B. Saunders & Co.: Chapter 79, 1996.

8. Lowe, F.C. and Klein, L.: Management of Scrotal Carcinoma. In Current

Management of Genitourinary Cancer Surgery, Edited by D. Crawford and S. Das, Lea

and Febinger: 545-549, 1996.

9. Klein, L.T. and Lowe, F.C.: The Effect of Digital Rectal Examination and Various

Lower Urinary Tract Procedures on Serum PSA Concentrations. Urol. Clinic

North Amer. 24: 293-298, 1997.

10. Lowe, F.C. and Standaert, B.: Health Economics of BPH. Benign Prostatic Hyperplasia—The Place of Alfusosin. Edited by Debruyne, FMJ et al. Adis: 103-118, 1998.

11. Staiman, V.R. and Lowe, F.C.: Urologic Problems in Patients with Acquired

Immunodeficiency Syndrome. Digital Urol. J. ., 1998.

12. Health Economics of BPH. Benign Prostatic Hyperplasia—The Place of Alfusosin. Edited by Debruyne, FMJ et al. Adis: 103-118, 1998.

13. Dreikorn, K., Borkowski, A., Braeckman, J., Denis, L., Ferrari, P., Gerber, G., Levin, R.,

Lowe, F.C., Perrin, P. Medical Therapies. In Proceedings of 4th.

International Consultation on Benign Prostatic Hyperplasia. Edited by Denis, L.,

Griffiths, K., Khoury, S. et al. Health Publication Ltd. 633-659, 1998.

14. Lowe, F.C., and Fagelman, E.: Phytotherapy in the Treatment of Prostatitis. In

Prostatitis Edited by J.C. Nickel, ISSIS Medical Media: 329-331, 1999.

15. Staiman, V.R. and Lowe, F.C..: Gynecomastia. In Five Minute Urology Consult,

Edited By L.G. Gomella, Lippincott, Williams and Wilkins, 58-59, 2000.

16. Kearney, M.C. and Lowe, F.C.: Squamous Cell Carcinoma of the Scrotum. In The Five

Minute Urology Consult, Edited by L.G. Comella, Lippincott, Williams and Wilkins.

494-495, 2000.

17. Taylor, J. and Lowe, F.C.: Alternative Therapies in Urology. In The Five Minute Urology

Consult, Edited by L.G. Gomella, Lippincott, Williams and Wilkins, 769-772, 2000.

18. Dreikom, K., Lowe, F.C., Borkowski, A., Buck, H.C., Braeckman, J., Denis, L., Ferrari, P

.,.: Habib, F., and Perrin, P., Other Medical Therapies. In Proceedings of 5th

International Consultation on Benign Prostatic Hyperplasia. Edited by Chatelin, C.,

Denis, L., Foo K.T. et. Al, Health Publications Ltd: 479-511, 2001.

19. Fagelman, E., and Lowe, F.C.: Herbal Medications in the treatment of BPH. Urol Clinic

North Amer. 29:31-48, 2002.

20. Lepor, H. and Lowe F.C.: Evaluation and Nonsurgical Management of Benign Prostatic Hyperplasia. In Campbell’s Urology, Eight Edition, Edited by P.C. Walsh, et al, W.B. Saunders & Co., 2002.

21. Johnson, W., Johnson, C. and Lowe, F.C.: Tuberculosis and Parasitic Diseases of the

Genitourinary System. In Campbell’s Urology, Eighth Edition, Edited by P.C. Walsh, et al, W.B.

Saunders & Co., 2002

22. Hyun, G. and Lowe, F.C.: AIDS and the Urologist. Urol Clinics of N. American. 30: 101-

109, 2003.

23. Fagelman, E., Mennite, B., and Lowe, F.C.: Complementary Medications in Urology. In Essential Urology edited by J.M. Potts, Humana Press: 225-234, 2004.

24. Fagelman, E. and Lowe, F.C.: Reviewers of clinical trials of saw palmetto berry, cranberry, pygeum, and

grass pollens. In The Handbook of Clinically Tested Herbal Remedies. Edited by M. Barrett, Haworth Herbal Press: 265-276, 773-786, 981-1010, 1043-1100, 2004.

25. Santillo, V.M. and Lowe, F.C.: Prostate Cancer and The Gay Male. In A Gay Man’s Guide to Prostate Cancer,

Edited by G. Perlman and J. Drescher, Haworth Medical Press: 9-27, 2005.

26. Lowe, F.C. and Moyad, M.: Alternative Urologic Therapies (Phytotherapies). In The Five

Minute Urology Consult, Edited by L.G. Comella, Lippincott, Williams and Wilkins: 725-729, 2010.

26. Wosnitzer, M.S. and Lowe, F.C.: Prostate Cancer Management in the HIV-Positive Patients in the Era of Highly-Active antiretroviral Therapy (HAART). In What Every Gay Man Needs to Know About Prostate Cancer.Edited by G. Pearlman. Magnus Books, 2013.

27. Santillo, V.M. and Lowe, F.C.: Quality-of-Life and Cancer Control after Prostate Cancer Treatment. In What Every Gay Man Needs to Know About Prostate Cancer.Edited by G. Pearlman. Magnus Books, 2013.

28. Wosnitzer, M.S., Ahn, J. and Lowe,F.C.: HIV and Prostate Cancer. Prostate Cancer: A Comptrehensive Perspective. Edited by Ashutosh Tewari. Springer, Chapter 10, 2013.

29. Tu, D and Lowe,F.C.: Nocturia: Treatment with alternative Therapies. In Nocturia. Edited by

J. Weiss and J. Blavais, Springer: 157-164, 2011.

30. Lowe, F.C.: A Straight Urologist Discusses Working with Gay Men Who Have Prostate Cancer. In What Every Gay Man Needs to Know About Prostate Cancer.Edited by G. Pearlman. Magnus Books, 2013.

31. Wenske, S and Lowe,F.C.: Complementary and Alternative Medicine. In The Five Minute Urology Consult,

Edited by L.G. Gomella, Wolters Kluwer, 2014.

Invited Miscellaneous Articles:

1. Lowe,F.C.: Book Review: Difficult Diagnosis in Urology by David McCullough.

Urol. 141:669, 1989.

2. Lowe,F.C.: Editorial Comment: Long-Term Follow-up Results After Expectant.

Management of Stage A1 Prostatic Cancer by Zhang, G., et al. J. Urol.

102-103, 1991.

3. Lowe,F.C.: Book Review: Cancer of the Prostate Edited by S. Das and

David Crawford. J. Urol. 150: 2040, 1993.

4. Lowe,F.C.: Safety and Efficacy of Terazosin in the Management of BPH.

AUA Today September, 1994.

5. Lowe,F.C.: Good News for Hypertensives with BPH. Modern Medicine

24, 1995.

6. Lowe,F.C.: Editorial: Diagnosis and Staging of Prostate Cancer.

Urol. 156: 114, 1996.

7. Lowe,F.C.: Editorial: Quality of Life After Partial Penectomy For Penile Carcinoma.

Urology 50: 596, 1997..

8. Lowe,F.C.: Editorial: Saw Palmetto Berry in Men with LUTS. Urology, 51: 1007, 1998.

9. Lowe,F.C.: What I Tell Patients About Phytotherapy for Lower Urinary Tract Symptoms.

AUA News, 5: (3) 12, 1998.

10. Lowe,F.C.: and Weber, M.L.: Defining the Link Between Benign Prostatic Hyperplasia

and Hypertension. Scientific Exchange, 1998.

11. Lowe,F.C.: Guidelines for the Evaluation and Management of BPH. Institute for Continuing Healthcare Education and Medicom of Princeton, 1998.

12. Lowe,F.C.: New Considerations in the Selection of Appropriate Alpha 1-Adrenergic

agonists in the Management of BPH. In New Concepts in Medical Management of

BPH, MPE Communications 4-8, 1998.

13. Narayan, P. (Moderator): Roundtable Discussion on BPH: Issues no the Use of Alpha

Urology Times 27: supplement #1, 1999.

14. Lowe, F.C.: Book Review. Testicular and Penile Cancer. J. Urol. 161: 736-736, 1999.

15. Lowe, F.C.: Chronic Prostatitis: An Update. In Diseases of the Prostate – A Postgraduate

Medicine Special Report 18-25, 1999.

16. Lowe, F.C.: Editorial: Natural Therapies: Questions, Uncertainties Abound. Urology Times.

(5): 2, 30, 2000.

17. Lowe, F.C.: Penile Enlargement: Think Hard Before Taking the Risk. Gay Health. Natural Therapies: Gayhealth. Com/templates. May, 2000.

18. Lowe, F.C.: Complementary Medications. In John Hopkins Medical Institutions Prostate.

Bulletin: 25-33, September 2000.

19. Lowe, F.C.: Editorial: Efficacy of Chemotherapy for Prostatic Tuberculosis – A Clinical and Histologic Follow-up Study. Urology 57: 877, 2001.

20. Lowe, F.C.: Editorial: Bacterial Interference for Preventing Urinary Tract Infections. Urology

58: 344, 2001.

21. Lowe, F.C.: Editorial: Acupuncture Ameliorates Symptoms in Men with Chronic Prostatitis/Chronic

Pelvic Pain Syndrome. Urology 61: 1159, 2003.

22. Lowe, F.C.: Benign Prostatic Hyperplasia and Hypertension. Urology Leader’s Forum, #1, 2004.

23. Lowe, F.C.: Editorial: Povidone Iodine and Dextrose Solution Combination Sclerotherapy in Chyluria.

Urology 64: 1110, 2004.

24. Lowe, F.C.: Editorial Comment: Are bone scans necessary in men with low prostate specific antigen levels

following localized therapy. J.Urol 176:73, 2006.

25. Lowe, F.C.: Editorial: Effects of One-Year Treatment with Isoflavone from Red Clover on Prostate,

Liver Function, Sexual Function and Quality of Life in Men with Elevated PSA Levels and Negative Prostate

Biopsy Findings. Urology 71: 190, 2008.

26. Lowe,F.C.: Editorial: Preliminary Results of Radiation Therapy for Prostate Cancer in HIV Positive Patients.

Urology 72: 1138, 2008.

27. Lowe,F.C.: Editorial: Contemporary Patients With Lower Urinary tract Symptoms Suggestive of Benign

Prostatic Hyperplasia Who Need Surgical Treatment Have Long-Term History of Treatment With Alpha 1 Blockers and Large Prostates Compared to Past Cases. Urology 74: 609, 2009.

28. Lowe,F.C. : Editorial: Silodosin in the treatment of BPH/LUTS. Urology 74: 1323, 2009.

Abstracts:

1. Oesterling, J.E., Bromberg, W.D. and Lowe F.C.: Localization of foreign body in the

penis using pre-operative xeroradiography and intra operative ultrasonography.

Mid-Atlantic Section of American Urological Association, September 28-31, 1986,

Southhampton, Bermunda.

2. Walsh, P.C. and Lowe, F.C.: Potency Following Radical Retropubic Prostatectomy

with Wide Unilateral Excision of the Neurovascular Bundle. Mid-Atlantic Section of

American Urological Association, September 28-31, 1986, Southampton, Bermunda.

3. Romas, N.A., Lowe, F.C. Clark L, MacKenzie, J.W. and Win, L: RNA

Catabolites As Cancer Markers in Urinary Tract Tumors. American Urological Potency Following Radical Association, June 3-7, 1988, Boston, MA.

4. Coleburn, N.H., Lowe, F.C. and Romas, N.A.: Renal Disease in patients with

AIDS and ARC. New York Section of American Urological Association,

September 24-31, 1988, Amsterdam, The Netherlands.

5. Nakhla, A.M., Romas, N.A., Lowe, F.C. and Rosner, W.: Estradiol Activates the Prostate

Androgen Receptor and PSA Secretion Through the Intemidiary of Sex Homone-,

Binding Globulin. 4th International Consultation on BPH, July 2-5, 1997, Paris, France.

6. Albert, P., Pellissier, J., Lowe, F.C., Giman, C. and Roehrborn, C.: Economic Implications

of Effects of Finasteride on The Rise of Acute Urinary Retention and Need for

Surgery. American Urological Association, May1-6, 1999, Dallas, Texas.

7. Boyle, P., Robertson, C., Lowe, F.C., Roehrborn, C.: Meta-Analysis of Permixon in

Treatment of Symptomatic Benign Prostatic Hyperplasia: An Update. American Urological

Association, April 28, 2003, Chicago, Illinois.

8. Levinson, A., Santillo, V.M., Hansen, A., Lowe, F.C.: Five Year Outcomes of Clinically Localized Prostate

Cancer in Patients with Human Immunodeficiency Virus. J Clin Oncology, 2008 ASCO Annual Meeting

Proceedings Part 1. Vol 26, #15s (May 20 supplement), 2008: 16095.

9. Roehrborn, C., Lowe, F.C., Gittelman M., Verbeek, A., Wruck, J.: . Management of Male Lower Urinary

Tract Symptoms: Ability to Correctly Identify and Consequences of Incorrect Consumer Decision.

Societe Urologe International, October 17, 2015, Sydney, Australia.

10. Gittelman, M., Roehrborn, C., Lowe, F.C.,Verbeek, A. and Wruck, J.: An Alternative Model for the Management of Lower Urinary Tract Symptoms Presumed to be Due to Benign Prostatic Hyperplasia. Societe Urologe International, October 16, 2015, Sydney, Australia.

11. Lowe, F.C , Gittelman, M., Roehrborn, C., Verbeel, A. and Wruck, J.: Microscopic Hematuria Screening in a Male Consumer Population with Lower Urinary Tract Symptoms. . Societe Urologe International, October 16, 2015, Sydney, Australia.

Scientific Presentations:

1. Wound Dehiscence in Exstrophy. American Academy of Pediatrics,

October 23-28, 1982, New York, NY.

2. Wound Dehiscence in Bladder Exstrophy: An Examination of the Etiologies

and Factors of Initial Failure and Subsequent Success. American Urological

Association, April 17-21, 1982, Las Vegas, Nevada.

3. A Study of Metastasis of Prostatic Cancer in the Dunning R-3327 Animal Model.

Mid-Atlantic Section of the American Urological Association, October 2-7, 1983,

Hot Springs, Virginia.

4. Illeal Trigonal Conduits: 10-Year Follow-up. Mid-Atlantic Section American

Urological Association, October 2-7, 1983, Hot Springs, Virginia.

5. Ureteropelvic Junction Obstruction in Adults. Mid-Atlantic Section American

Urological Association, October 2-7, 1983, Hot Springs, Virginia.

6. Ileal Trigonal Conduits: 10 Year Follow-Up. American Academy of Pediatrics,

October 28-31, 1981, San Francisco, California.

7. Urethral Prolapse: A Clinical and Anatomical Study. Mid-Atlantic Section of the

American Urological Association, November 1-4, 1984, White Sulphur Springs,

West Virginia.

8. Monitoring Radiation Exposure to Medical Personnel during Percutaneous

Nephrolithotomy. Mid-Atlantic Section of the American Urological Association

November 1-4, 1984, White Sulphur Springs, West Virginia.

9. Urethral Prolapse: Identification of the Anatomical Defects and Insights into

its Management. Society of University Urology Residents, May 8-11, 1985,

Pine Mountain, Georgia.

10. Monitoring Radiation Exposure to Medical Personnel during Percutaneous

Nephrolithotomy. American Urological Association, May 12-1, 1985, Atlanta,

Georgia.

11. Potency Following Radical Retropubic Prostatectomy with Wide Unilateral Ex-

cision of the Neurovascular Bundle. New York Section of the American

Urological Association, October 27-31, 1986, Laguna Nigel, California.

12. Indications for the Use of Ketoconazole in the Initial Management of Prostate

Cancer. American Urological Association, May 17-21, 1987, Anaheim, California.

13. The Epidemiology of Kaposi’s Sarcoma of the Penis in Patients with Acquired

Immune Deficiency Syndrome. American Urological Association, June 3-7, 1988,

Boston, Massachusetts.

14. Renal Failure in Patients with AIDS Related Complex. American Urological

Association, May 7-11, 1989, Dallas, Texas.

15. Terazosin: Efficacy and Safety in the Treatment of BPH. New York Section,

American Urological Association, October 19-24, 1992, Berlin, Germany.

16. The Role of Bone Scans in the Evaluation of Newly Diagnosed Prostate Cancer

in the PSA Era: A Critical Reappraisal. New York Section, American Urological

Association, October 19-24, 1992, Berlin, Germany.

17. The Economic Impact of Using PSA to Elimate the Staging Radionuclide Bone Scan

in Select Patients with Newly Diagnosed Prostate Cancer. American

Urological Association, May 15-20, 1993, San Antonio, Texas.

18. Oral Medical Therapy for the Treatment of Prostaglandin Induced Prolonged

Erections. American Urological Association, May 15-20, 1993, San Antonio,

Texas.

19. Long Term Safety and Efficacy of Terazosin in the Treatment of BPH: An

Interim Analysis. New York Section, American Urological Association,

Oct. 10-16, 1993, Venice, Italy.

20. Safety Assessment of Terazosin in the Treatment of BPH. American Geriatrics

Society, May 9-12, 1994, Los Angeles, California.

21. Safety Assessment of Terazosin in the Treatment of Patients with Symptomatic

BPH. A Combined Analysis. Mid-Atlantic Section, American Urological Association.

September 24, 1994, Philadelphia, Pennsylvania.

22. Safety Assessment of Terazosin in BPH. Northeastern Section, American Uro-

logical Association, September 25-29, 1994, Bolton’s Landing, New York.

23. Blood Pressure effects of Men with Prostatism Concurrently Treated with Anti-

hypertensives and Terazosin. American Urological Association, April 24, 1995,

Las Vegas, Nevada

24. Economic Modeling to Assess Cost-Effectiveness of BPH Therapies. International

Society of Technology Assessment in Health Care, June 6, 1995, Stockholm, Sweden.

25. Indications for the Use of Magnetic Resonance Urography. American Urological Association,

May 6, 1996, Orlando, Florida.

26. Creation of a Markov Model to Assess the Cost-Effectiveness of Various treatments

for BPH. American Urological Association, May 7, 1996, Orlando, Florida.

27. Follow-up of High Grade PIN: Clinical Implications. American Urological Association,

May 7, 1996, Orlando, Florida.

28. Clinical Implication of High Grade PIN, New York Section, American Urological

Association, October 6-11, 1996, Paris, France.

29. Concomitant Use of Tamsulosin With Antihypertensives: The Lack of Clinically

Significant Interactions. American Urological Association, April 12, 1997,

New Orleans, LA.

30. The Treatment of Flutamide and Finasteride Induced of Painful Gynecomastia with

Tamoxifen. American Urological Association, April 14, 1997, New Orleans, LA.

31. Concomitant Use of Tamsulosin. 4th International Consultation on BPH, July 2-5

1997, Paris, France.

32. Terazosin Treatment of Concomitant Symptomatic Benign Prostatic Hyperplasia and

Isolated Systolic Hypertension. Societe International Urologie, Sept. 11, 1997, Montreal

Canada..

33. Phytotherapy for BPH, New York Section, American Urological Association,

Lisbon, Portugal, October 22, 1997.

34. New Medical Therapies for BPH New York Section, American Urological Association,

Lisbon, Portugal, October 22, 1997.

35. 4 Month Safety and Efficacy of Terazosin in the Treatment of Symptomatic BPH.

European Association Urology, Iona, Spain, March 21-24, 1998.

36. Meta analysis of the treatment of BPH with Permixon. American Urological

Association, June 1, 1998, San Diego, CA, June 1, 1998.

37. The Effects of Tamsulosin Upon Serum PSa and Lipid Levels. New York Section,

American Urological Association, Oct. 14, 1998, Prague, Czech Republic.

38. Efficacy and Tolerability of Tamsulosin in Patients less than 65 Years and

greater than 65 years with benign prostatic hyperplasia, American Urological

Association, May 4, 1999, Dallas, Texas.

39. Prospective Randomized, Multicenter Trial to Evaluate the Rapidity of Onset and Side-

Effect Profile of Tamsulosin versus Terazosin in Men with Benign Prostatic Hyperplasia.

European Urological Association, February 25, 2002, Birmingham, England.

40. Epidemiological Evidence of Increased Prostate Cancer Detection in Particularly Younger

Men Aged 50-59: A Review of 311,655 Biopsies Performed From 1995-2001. American

Urological Association, May 26, 2002, Orlando, FL.

41. Prospective Clinical Trial Comparison of Tamsulosin and Terazosin. American Urological

Association, May 28, 2002, Orlando, FL.

42. Finasteride Therapy for BPH: 10 Year Follow-UP. American Urological Association,

May 29, 2002, Orlando, FL. Association, May 28, 2002, Orlando, FL.

43. Analysis of 233,989 Prostate Biopsies From 1997 to 2002 Confirms the Trend of

Decreasing Age of Patients Undergoing Prostate Biopsy But Does Not Demonstrate Any

Alteration in the Overall Detection Rate of Prostate Cancer. American Urological

Association, April 27, 2003, Chicago, IL.

44. Epidemiological Evidence Suggesting a PSA Cut-Point of 2.5 NG/ML For Initiating A

Prostate Biopsy: A Review of 36,316 Patients With Biopsy and PSA Data. American

Urological Association, April 29, 2003, Chicago, IL.

45. Changing Patterns of Prostate Biopsy Techniques From 1997 to 2002: A Review of 233, 989 Biopsies. American Urological Association, April 30, 2003, Chicago, IL.

46. Diet, Supplements and Drugs in the Prevention of Prostate Cancer. New York Section, American Urological

Association, October 12, 2003, Athens, Greece.

47. Long-term Management of BPH with Finasteride Monotherapy: 10 Year Follow-Up. New York Section,

American Urological Association, October 13, 2003, Athens, Greece.

48. Economic Comparison of Uro-selective Alpha-Blockers in the Management of BPH. New York Section,

American Urological Association, October 15,2003, Crete, Greece.

49. Risk Factors for Disease Progression in Patients with Lower Urinary Tract Symptoms/BPH: a Systematic

Analysis of Expert Opinion. European Association of Urology, March 25, 2004, Vienna, Austria.

50. Clinical Management of BPH: What is the right place of Serenoa repens? European Association of Urology,

Stockholm, Sweden, March 18, 2009.

51. Phytotherapy for Treatment of BPH: Fact or Fiction. National Medical Association, Las Vegas NV, July 27,

2009.

52. Treating prostate cancer in the HIV positive patient. NY AUA, Juneau, Alaska, August 24, 2009.

53. Complementary Medicine in Urology. NY AUA, Seward, Alaska, August 21, 2009.

54. The Use of Complementary Medicine in Urology: What is the Evidence? Arabian Urological, Cairo, Egypt,

October 10, 2009.

55. Genitalial Manifestations of Medical Diseases. New York Section, American Urological

Association, Krakow, Poland, October 5, 2010.

56. The Role of Anti-Androgens in the Management of Prostate Cancer. New York Section, American Urological

Association, Normandy, France, September 13, 2011.

57. Management of Male Lower Urinary Tract Symptoms: Ability to Correctly Identify and Consequences of

Incorrect Consumer Decision. International Continence Society, Montreal, Canada, October 7, 2015.

58. Microscopic Hematuria Screening in a Male Consumer Population with Lower Urinary Tract Symptoms.

International Continence Society, Montreal, Canada, October 7, 2015.

Invited Lectures:

1. Skin Cancer of the Male Genitalia. Dermatology Grand Rounds, The Johns

Hopkins Hospital, December 22, 1983.

2. Advances in the Management of Localized Prostate Cancer: Potency-Preserving

Radical Retropubic Prostatectomy. Urology Grand Rounds, Maimonades Hospital

November 22, 1985, Brooklyn, New York.

3. Current Advances in Prostate Cancer. Urology Grand Rounds, New York

Hospital, October 23, 1986, New York, New York.

4. Current Advances in Hormonal Therapy for Metastasis Prostate Cancer. Urology

Grand Rounds, New York University Hospital, February 23, 1987, New York, NY.

5. Ketoconazole in the Management of Prostate Cancer. Urology Grand Rounds,

John Hopkins Hospital, April 14, 1987, Baltimore, Maryland.

6. Urological Cancer in Men. American Cancer Society. June 1, 1988, New York,

New York.

7. Cancer of the Male Genitalia. Urology Grand Rounds, Bowman Grey Medical

Center. June 20, 1990, Winston-Salem, North Carolina.

8. State of the Art: Alpha Sympatholytic Therapy for the Treatment of BPH

New York Section of the American Urological Association, October 1-6, 1990

Budapest, Hungary.

9. Hormonal Therapy for Prostate Cancer, Suffolk County Urology Association

April 25, 1991, Smithtown, New York.

10. Current Advances in Treatment of Prostatic Hypertrophy. Departments of

Pharmacology and Molecular Biology and Medicine Grand Rounds, The

Chicago Medical School, September 4, 1991, Chicago, IL.

11. Therapy of Chronic Prostatitis. Research Seminar, Abbott Laboratories,

September 5, 1991, Chicago, IL.

12. Cancer of the Male Genitalia. Urology Grand Rounds, Lenox Hill Hospital,

September 26, 1991, New York, NY.

13. Non-Surgical Therapies for BPH. Medical Grand Rounds, St. Vincent’s Medical

Center, April 21, 1992, Bridgeport, CT.

14. Urological Manifestations of AIDS. Medical Grand Rounds. Elizabeth General

Hospital, May 20, 1992, Elizabeth, NJ.

15. Update on Prostate Cancer. Tumor Board Conference, Sacred Heart Hospital,

May 29, 1992, Allentown, PA.

16. Alternate Therapies for BPH. Medical Grand Rounds, Valley Hospital,

June 17, 1992, Ridgewood, NJ.

17. Update on the Medical Management of BPH. Urology Grand Rounds,

Wayne General Hospital, October 8, 1992, Wayne, NJ.

18. New Perspectives in the Management of Benign Prostatic Hyperplasia, Urology

Rounds, Overlook Hospital, November 4, 1992, Summit, NJ.

19. Evaluation of BPH. Primary Care Rounds, St. Mary’s Hospital, November 10, 1992,

Hoboken, NJ.

20. Current Management of BPH. Medical Grand Rounds, Passaic General Hospital,

November 18, 1992, Passaic, NJ.

21. New Approaches to the Treatment of BPH. Medical Rounds, Brunswick Hospital,

January 21, 1993, Amityville, NY.

22. New Approaches to the Treatment of BPH. Medical Rounds, St. Francis Hospital,

January 26, 1993, Jersey City, NJ.

23. Treatment BPH in 1993. Medical Grand Rounds, Bergen Pines

Hospital, January 27, 1993, Paramus, NJ.

24. Management of BPH. Medical Ground Rounds, Warren General Hospital,

March 3, 1993, Philipsberg, NJ.

25. Medical Management of BPH. Medical Grand Rounds, Holy Name Hospital,

March 9, 1993, Teaneck, NJ.

26. Screening and Detection of Prostate Cancer in the Primary Care Setting.

Connecticut State Medical Society. March 10, 1993, Hartford, CT.

27. Prostate Cancer: Epidemiology, Natural History, Diagnosis and Staging.

New York Section, American Urological Association, Post-Graduate Seminar,

March 20, 1993, New York, NY.

28. Treatment Options in the Treatment of BPH. Eastern Regional Oestopathic

Convention, April 15-18, 1993, Atlantic City, NJ.

29. A Multicenter Sudy of Terazosin in the Treatment of BPH. Urology Advisory

Council: Future Directions in Research and Clinical Practice, April 30, 1993.

Abbott Park, IL.

30. Medical Treatment Options: A Comparison of Clinical Efficacy. Urology Advisory

Council: Future Directions in Research and Clinical Practice,

April 30, 1993, Abbott Park, IL.

31. Alpha Blockade in the Management of Benign Prostatic Hyperplasia. New York

Section, American Urological Association, June 26, 1993, Montauk, NY.

32. State of the art: Continent Urinary Diversion. New York Section, American

Urological Association, October 10-16, 1993, Florence, Italy.

33. Current Status of Alpha Blockade in the Management of BPH. Urology Grand

Rounds, Hackensack Medical Center, November 18, 1993, Hackensack, NJ.

34. Medical Management of BPH. Primary Care Grand Rounds, Wyckoff Medical

Center, January 11, 1994, Brooklyn, NY

35. Alpha Blockers in the Management of BPH. Urology Grand Rounds, Long Island

Jewish Hospital, March 10, 1994, Hillside, NY.

36. Current Controversies is the Management of Prostate Cancer. Monmouth County

Urological Association, March 16, 1994, Spring Lake, NJ.

37. Alpha Blockers in BPH. Bergen-Passaic County Osteopathic Society,

April 5, 1994, Ridgewood, NJ.

38. Advances in the Hormonal Therapy of Prostate Cancer. Oncology Grand

Rounds, Beth Israel Hospital, April 6, 1994, New York, NY.

39. Medical Management of BPH, Medical Grand Rounds, Central Suffolk Hospital

April 7, 1994, Riverhead, NY.

40. Management of BPH, Medical Grand Rounds, Bergen Pines Hospital,

April 13, 1994. Paramus, NJ.

41. Genitalia Malignancies. Urology Grand Rounds, New York University Hospital,

May 11, 1994, New York, New York

42. Combined Androgen Deprivation Therapy for Prostate Cancer. Urology Rounds,

Good Samaritan Hospital, May 26, 1994, West Islip, NY.

43. Medical Management of BPH, Medical Grand Rounds, St. Charles Hospital,

June 7, 1994, Port Jefferson, New York

44. Prostate Cancer Update. Medical Grand Rounds, South Nassau Community Hospital,

June 14, 1994, Oceanside, New York

45. Gangrene of Genitalia. New York Section, American Urological Association,

June 4, 1994, Rye Brook, NY.

46. Natural History of Prostate Cancer. New York Section, American Urological Association,

June 4, 1994, Rye Brook, NY.

47. Medical Management of BPH. Urology in the 1990’s Seminary, October 22, 1994,

Orlando, FL.

48. Treatment of BPH. New York State Physician’s Assistants Annual Meeting

October 22, 1994, Saratoga Springs, NY.

49. Pharmacotherapy for BPH. Austrian Urological, November 10, 1994, Salzburg, Austria.

50. Hormonal Therapy for Prostate Cancer. Oncology Rounds, Lenox Hill Hospital

January 17, 1995, New York, NY.

51. Treatment of Metastatic Prostate Cancer. Urology Rounds, Brookdale Hospital

January 18, 1995, Brooklyn, NY.

52. Pharmacotherapy for BPH. Primary Care Grand Rounds, All Saints Hospital,

February 28, 1995, Fort Worth, Texas.

53. Pharmacotherapy for BPH. Combined Urology and Medicine Rounds, Southside

Hospital, March 3, 1995, East Islip, NY.

54. Genitourinary Manifestations of AIDS. New York Section AUA, The Greater

New York Urology Symposium, March 4-5, 1995, New York, NY.

55. Evaluation and Treatment of BPH, Primary Care Rounds, Brookhaven Hospital,

April 21, 1995, East Patchogue, NY.

56. A.H.C.P.R. Guidelines for the Treatment of BPH. Primary Care Rounds,

Charlotte Hungerford Hospital, April 26, 1995, Torrington, CT.

57. A.H.C.P.R. Guidelines for the Treatment of BPH. Medical Grand Rounds.

St. Joseph’s Hospital, April 27, 1995, Syracuse, NY.

58. Epidemiology, Natural History and Etiology of BPH, National Association

Managed Care Physicians, May 11, 1965, Palm Springs, CA.

59. The HYCAT Study. National Association Managed Care Physicians,

May 11, 1995, Palm Springs, CA.

60. Natural History of BPH. Academy of Managed Care Pharmacists, May 18, 1995

Toronto, Canada.

61. The HYCAT Study. Academy of Managed Care Pharmacists, May 15, 1995,

Toronto, Canada.

62. BPH: Pathophysiology, Diagnosis and Treatment. Medical Grand Rounds,

St. Benedictine Hospital. June 10, 1965, Kingston, NY.

63. Current Advances in the Hormonal Therapy of Prostate Cancer. Medical Rounds,

Our Lady of Mercy Hospital, June 21, 1995, Bronx, NY.

64. BPH: A.H.C.P.R. Guidelines. Primary Care Rounds, Lenox Hill Hospital,

July 21, 1995, New York, NY.

65. Prostate Disease: BPH and Cancer. Medical Staff Conference, Peninsula General

Hospital, September 14, 1995, Queens, NY.

66. BPH: A.H.C.P.R. Guidelines, Medical Grand Rounds, St. John’s Riverside

Hospital, September 26, 1995, Yonkers, NY.

67. BPH: Pathophysiology, Diagnosis and Treatment. Medical Grand Rounds,

Franklin Hospital, September 28, 1995, Valley Stream, NY.

68. BPH: Pathophysiology, Diagnosis and Treatment. Medical Grand Rounds,

VA Medical Center, October 11, 1995, NJ.

69. Intermittent Androgen Ablation for Prostate Cancer. Oncology Rounds,

Winthrop Hospital, October 14, 1995, Mineola, NY.

70. BPH: Evaluation and Management, Medical Records. VA Medical Center,

November 8, 1995, East Orange, NJ.

71. Urinary Tract Infections in HIV Positive Patients. Medical Society of Delaware.

Infectious Disease Update: 1995, November 14, 1995, Wilmington, DE.

72. BPH: Evaluation and Management Medical Rounds. Clara Mass Medical Center,

December 6, 1995, Belleville, NJ.

73. BPH: Epidemiology, Diagnosis and Management. Medical Grand Rounds, VA

Medical Center, December 21, 1995, Buffalo, NY.

74. Phytotherapy for BPH: BPH Update Symposium, February 2, 1996, San Diego, CA.

75. Economic Modeling for BPH. BPH Update Symposium, February 3, 1996, San Diego, CA

76. Symptoms of BPH, New York Section, American Urological Association 1996, Annual

Urology Symposium, March 10, 1996, New York, NY.

77. Urinary Tract Infections in AIDS. Visiting Professor Lecture, Washington, D.C.

Urological Society, March 21, 1996, Washington, DC.

78. Prostatitis. Primary Care Grand Rounds, Holy Name Hospital, April 23, 1996,

Teaneck, NJ.

79. Evaluation and Management of BPH. Medical Housestaff Rounds, St. Vincent’s

Hospital, November 13, 1996, New York, NY.

80. Phytotherapy for BPH. Seventh Nutraceutical Conference, November 20, 1996,

New York, NY.

81. New Advances in Treatment of Prostate Cancer. Tumor Board, Kuakini Medical Center,

March 20, 1997, Honolulu, HI.

82. Prostate Cancer Update. Oncology Conference, Queen’s Medical Center,

March 20, 1997, Honolulu, HI.

83. Phytotherapy for BPH. Visiting Professor Lecture, Tripler Army Medical Center,

March 25, 1997.

84. AIDS and the Urologist. Visiting Professor Lecture, Tripler Army Medical Center,

March 25, 1997.

85. Prostate Cancer Case Reviews. Visiting Professor Lectures, Tripler Army Medical

Center, March 26, 1997.

86. Currents Advances in Diagnosis and Management of Prostate Cancer. Joint

Medical Rounds, Encino-Tarzana Regional Medical Center, March 27, 1997.

Tarzana, CA.

87. Update on Prostate Cancer. Chilton Memorial Hospital, Pompton Plains, NJ,

June 27, 1997.

88. Alternative Hormonal Therapies for Prostate Cancer. Department of Urology

Jefferson Medical School Annual Urology Update, Philadelphia, PA, October 30, 1997.

89. New Medical Therapies for BPH. Urology Grand Rounds, SUNY-Syracuse,

December 18, 1997.

90. Medical Therapies for BPH. Medical Grand Rounds, Lincoln Hospital, Bronx, NY

December 19, 1997.

91. Urological Manifestation of AIDS. Urology Grand Rounds, Henry Ford Hospital,

Detroit, MI, January 31, 1998.

92. What do you want to achieve in treating BPH? Satellite Symposium, European

Association Urology, Barcelona, Spain, March 21, 1998.

93. Tamsulosin and other Medical Therapies for BPH. Northern Miami Urological

Society, Miami, Florida, April 23, 1998.

94. Phytotherapy for BPH: A Critical Appraisal. Delaware Urological Society,

Wilmington, DE, April 24, 1998.

95. Phytotherapy for BPH. Visiting Professor Lecture, Illinois Urological Society,

Delavan, WI, September 11, 1998.

96. Urological Manifestations of AIDS. Visiting Professor Lecture, Illinois Urological

Society, Delavan, WI, September 12, 1998.

97. Evaluation and Management of BPH. Medical Grand Rounds, St. Joseph’s Hospital,

Baltimore, MD, September 16, 1998.

98. Cranberry Juice and Cipro: A Virtual Case. Tenth Nutraceutical Conference, New York, NY

November 1998.

99. Treatment of BPH: Goals of Therapy. Urology Grand Rounds. Stony Brook Medical Center,

Stony Brook, NY, February 5, 1999.

100. Comparison of Alpha Blockers, AUA Post-Graduate Course, Dallas, TX,

May 4, 1999.

101. The Role of Anti-Androgen Therapy in The Treatment of Prostate Cancer. Prostate

Cancer Update. Beth Israel Hospital, New York, NY, June 18, 1999.

102. Complementary Medications in the Treatment of BPH. Urology Grand Rounds. Beth

Israel Hospital, New York, NY, September 2, 1999.

103. Alternative Medications for BPH. AUA Post-Graduate Course, Atlanta, GA,

May 3, 2000.

104. Goals of Therapy for BPH. Fifth International Consultation on BPH, Paris, France,

June 26, 2000.

105. Complementary Medications for BPH. Visiting Professor Lecture, Arizona Urological

Society, Tucson, AZ, October 14, 2000.

106. Genitalia Manifestations of Medical Diseases. Visiting Professor Lecture, Arizona

Urological Society, Tucson, AZ, October 14, 2000.

107. Complementary Medications for BPH. Western Section, American Urological

Associate, Palm Springs, CA, November 6, 2000.

108. Genitalia Diseases. Urology Grand Rounds. Mt. Sinai Hospital, New York, NY

May 16, 2001.

109. Goals of Therapy in BPH. Satellite Symposium, American Urological Associate,

Anaheim, CA June 1, 2001.

110. Complementary Medications for BPH. AUA Post-Graduate Course, Anaheim, CA,

June 3, 2001.

111. Genital Diseases. Urology Grand Rounds. New York Medical College, Valhalla, NY,

August 16, 2001.

112. Medical Therapy for BPH. Visiting Professor Lecture, Urology Grand Rounds, Valhalla, NY

August 16, 2001.

113. Complementary and Alternative Medicine Usage in Urology. CAP CURE Symposium on

PC-SPES, Los Angeles, CA, October 15, 2001.

114. Alternative Therapy for Prostate Cancer. Urology Grand Rounds, University of Chicago,

Chicago, IL, October 31, 2001.

115. Alternative Therapy for Prostate Cancer. Urology Grand Rounds, John Hopkins Hospital

Baltimore, MD, November 8, 2001..

116. Phytotherapy for BPH. Urology Grand Rounds, New York Cornell Hospital, New York, NY,

December 13, 1001.

117. New Medical/Herbal Approaches in the Treatment of BPH. AUA 100th Anniversary

Celebration Meeting, New York, NY, February 16, 2002.

118. Complementary Medications for BPH. AUA Post-Graduate Course, Orlando, FL

June 2, 2002.

119. Androgen Supplementation and Prostate Safety. Third International Consultation on

Prostate Cancer, Paris, France, June 23, 2002.

120. Urological Manifestations of HIV Disease. Visiting Professor Lecture, Puerto Rican

Urological, San Juan, PR, November 14, 2002.

121. Alternative Hormonal Therapy for the Treatment of Prostate Cancer. Visiting Professor

Lecture, Puerto Rican Urological, San Juan, PR, November 14, 2002.

122. Long-term Medical Management of BPH. Visiting Professor Lecture, Puerto Rican

Urological, San Juan, PR, November 16, 2002.

123. Alternative Therapies in Urology, Visiting Professor Lecture, Puerto Rican Urological,

San Juan, P.R., November 16, 2002.

124. Complementary Medications for BPH. AUA Post-Graduate Course, Chicago, IL,

April 29, 2003.

125. MTOPS: It’s Impact Upon BPH Management. Long Island Jewish Hospital Men’s

Health Symposium, New Hyde Park, New York, NY, May 31, 2003.

126. Prevention of Prostate Cancer: Diet, Drugs and Supplements. Long Island Jewish

Hospital Men’s Health Symposium, New Hyde Park, NY, June 1, 2003.

127. Alternative Therapies in the Prevention and Treatment of Prostate Cancer. 51st Kimbrough

Urological Seminar, San Antonio, Texas, January 14, 2004.

128. Patient Risk Profiles for LUTS/BPH Progression. European Association of Urology, Austria, Vienna,

March 24, 2004.

129. Complementary Medications for BPH: Fact or Fiction? AUA Post-Graduate Course, San Francisco, CA,

May 9, 2004.

130. BPH Management in 2004. Medical College of Virginia Urology Grand Rounds, Richmond, VA, August 6, 2004.

131. BPH/LUTS and Sexual Dysfunction: Implications in Treatment and Management. Satellite Symposium, Societie of International Urology, Honolulu, HA, October 4, 2004.

132. Medical Therapy for BPH: Are All Drugs Equal? University of Wisconsin LUTS Symposium, Madison, WI, October 16, 2004

133. Herbal Preparations for BPH: Mechanism of Action. University of Wisconsin LUTS Symposium, Madison, WI, October 16, 2004.

134. Genitalial Diseases. Lent Visiting Professor Lecture, SUNY Buffalo, Buffalo, NY, May 5, 2005.

135. Pathophysiology and Management of BPH. Lent Visiting Professor Lecture, SUNY Buffalo, Buffalo, NY,

May 6, 2005.

136. Alternative Medications for BPH. AUA Post-graduate course. San Antonio, Texas, May 24, 2005

137. CAM in Urology. Basic Science Research Seminar, AUA Annual meeting, San Antonio, Texas,

May 22, 2005.

138. Phytotherapy for BPH: Fact or Fiction. Marie Jong Visiting Lecturer, Ohio State Urological meeting,

Cincinnati, Ohio, March 18, 2006.

139. Evidence based complementary and alternative medicine in Urology: State-of- the Art. American Urological

Association, Atlanta, GA, May 22, 2006.

140. Alternative Medications for BPH. AUA Post-graduate course. Atlanta, GA, May 22, 2006.

141. CAM in Urology. Piedmont Urological Association, Camden, NJ, June 27, 2006.

142. The Management of Prostate Cancer in HIV Positive Patients. Visiting Professor, Mexican Urological Society.

Puerta Vallarta, Mexico, November 17, 2006.

143. Complementary and Alternative Medicine in Urology. Visiting Professor, Mexican Urological Society,

Puerta Vallarta, Mexico, November 18, 2006.

144. Complementary Medicine in Urology. AUA Post-graduate Course. Anaheim, CA, May 16, 2007.

145. Diseases of the Genitalia. Johns Hopkins Urology Rounds, Baltimore, MD, August 28, 2008.

146. Diseases of the Genitalia. Urology Grand Rounds, Lennox Hill Hospital, New York, NY, March 25, 2010.

146. Genitalial Manifestations of Medical Diseases. Urology Grand Rounds, Montefiore Hospital, March 12, 2011.

147. Highlights of AUA: Infection/Imflammation. Plennary Session, AUA Annual Meeting, Atlanta, Georgia,

May 22, 2012.

148. What I Tell My Patients About Vitamins and Supplements. Urology Grand Rounds, Montefiore Hospital,

June 7, 2014.

149. Vitamins and Supplements In Urology, Urology Grand Rounds, Mount Sinai, October 6, 2014.

.

-----------------------

4

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download